Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Aug 01, 2012 (Vol. 32, No. 14)


  • Highlights latest additions to database
  • One search field not functional

I think it is sometimes forgotten that just because scientists have sequenced the human genome, that doesn’t mean that we previously had (or even have now) complete genomic sequences for many “lower” eukaryotes. Indeed, researchers are actively continuing the daunting quest to provide complete genomic information for a large number of high-interest organisms. To get the latest updates on the many eukaryotic genomics sequencing projects currently under way, visit diARK.org. This site has compiled data from 2,459 projects covering 1,086 species. The homepage features a highlighted organism, as well as a listing of the most recent genome assemblies and genome publications in the database. The website also contains a nice links page that directs visitors to other sequencing projects and a few taxonomy databases. I found one search feature on the “species” page to be broken, but visitors to the site can still search the database via the search bar displayed on the homepage.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »